EpiPen maker Mylan faces proposed class action lawsuit in U.S.

Tuesday, April 4, 2017 - 10:01 in Mathematics & Economics

Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $600 US for a two-pack of the device from less than $100 in 2007.

Read the whole article on CBC: Health

More from CBC: Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net